ex.VAT:
VAT:
inc.VAT:

Monday, January 19, 2009Market

Despite the crisis, Pierre Fabre continues to invest

undefined

71 million euros, this is what the Pierre Fabre dermocosmetics group will devote to increasing production capacity at its Soual site in the Tarn region. Ultimately, the operation should also create 150 jobs.

Reading time
~ 1 minutes

20 January 2009
In times of crisis, good news is not so frequent.

Laboratoires Pierre Fabre have just announced an investment of 71 million euros in their Soual plant, which manufactures creams, shampoos, lotions and gels sold under the Avène, Ducray, A-Derma, Galenic, Klorane and René Furterer brands. The objective is to increase its production capacity by 60 million units to support the development of international activities.

The press release published by the group states that this commitment confirms its willingness to invest in France and more specifically in its region of origin, which accounts for nearly half of its workforce. Pierre Fabre employs nearly 10,000 people worldwide.

This content is only available to subscribersPREMIUM, PRO, STARTUP and TPE

Already subscribed?Log in

Discover our subscriptions

Get your quotation now!

MarketOther articles